Spots Global Cancer Trial Database for fgfr3 overexpression
Every month we try and update this database with for fgfr3 overexpression cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours | NCT05363605 | Advanced Solid ... Head and Neck S... Bladder Carcino... Susceptible FGF... FGFR3 FGFR3 Overexpre... FGFR3 Receptor FGFR3 Protein O... Ovarian Cancer Colorectal Canc... Breast Cancer Liver Cancer Lung Cancer Gastric Cancer | [225Ac]-FPI-196... [111In]-FPI-196... vofatamab | 18 Years - | Fusion Pharmaceuticals Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
